Выходит 6 номеров в год
ISSN Печать: 0743-4863
ISSN Онлайн: 2162-660X
Indexed in
Gastric Retentive Dosage Forms: A Review
Краткое описание
Gastric retentive dosage forms have been investigated to provide controlled release therapy for drugs with reduced absorption in the lower gastrointestinal (GI) tract or for local treatment of diseases of the stomach or upper GI tract. Gastric retentive dosage forms rely on either natural GI physiology, such as floating or large tablets that depend on delayed emptying from the fed stomach, or those dosage forms that are designed to fight the physiology and avoid emptying in the fasted state through dosage forms of even larger sizes with or without flotation or bioadhesion. To understand the behavior of the dosage forms, an introduction to GI motility and its measurement is provided. Because the fed mode underlies the successful development of dosage forms that rely on size or flotation, the emptying of these dosage forms in the fed mode and identification of the key factors influencing the variability of gastric retention are discussed. The design and limitations of size or density-based fed mode, and mucoadhesive and expandable fasting-state gastric retentive systems are presented.
-
Schwartz Sherwyn L, Wu Jacqueline F, Berner Bret, Metformin extended release for the treatment of Type 2 diabetes mellitus, Expert Opinion on Pharmacotherapy, 7, 6, 2006. Crossref
-
Gomez-Orellana Isabel, Strategies to improve oral drug bioavailability, Expert Opinion on Drug Delivery, 2, 3, 2005. Crossref
-
Kagan Leonid, Hoffman Amnon, Systems for region selective drug delivery in the gastrointestinal tract: biopharmaceutical considerations, Expert Opinion on Drug Delivery, 5, 6, 2008. Crossref
-
Schwartz Sherwin L, Gordi Toufigh, Hou Eddie, Cramer Marilou, Heritier Michelle, Cowles Verne E, Clinical development of metformin extended-release tablets for type 2 diabetes: an overview, Expert Opinion on Drug Metabolism & Toxicology, 4, 9, 2008. Crossref
-
Berner Bret, Cowles Verne E, Case studies in swelling polymeric gastric retentive tablets, Expert Opinion on Drug Delivery, 3, 4, 2006. Crossref
-
Lewin Andrew, Lipetz Robert, Wu Jacqueline, Schwartz Sherwyn, Comparison of extended-release metformin in combination with a sulfonylurea (glyburide) to sulfonylurea monotherapy in adult patients with type 2 diabetes: a multicenter, double-blind, randomized, controlled, phase III study, Clinical Therapeutics, 29, 5, 2007. Crossref
-
Gordi Toufigh, Hou Eddie, Kasichayanula Sreeneeranj, Berner Bret, Pharmacokinetics of gabapentin after a single day and at steady state following the administration of gastric-retentive- extended-release and immediate-release tablets: A randomized, open-label, multiple-dose, three-way crossover, exploratory study in healthy subjects, Clinical Therapeutics, 30, 5, 2008. Crossref
-
Tao Yunying, Lu Yifan, Sun Yinjing, Gu Bing, Lu Weiyue, Pan Jun, Development of mucoadhesive microspheres of acyclovir with enhanced bioavailability, International Journal of Pharmaceutics, 378, 1-2, 2009. Crossref
-
Omidian Hossein, Park Kinam, Oral Targeted Drug Delivery Systems: Gastric Retention Devices, in Oral Controlled Release Formulation Design and Drug Delivery, 2010. Crossref
-
Davis Stanley S., Formulation strategies for absorption windows, Drug Discovery Today, 10, 4, 2005. Crossref
-
Kagan Leonid, Hoffman Amnon, Selection of drug candidates for gastroretentive dosage forms: Pharmacokinetics following continuous intragastric mode of administration in a rat model, European Journal of Pharmaceutics and Biopharmaceutics, 69, 1, 2008. Crossref
-
Audu Momohmumuni, Umale Adikwu Michael, Chinnedu Ibezim Emmanuel, Formulation and evaluation the bioadhesive properties of drug delivery system based on PEGylated mucin matrices, Asian Pacific Journal of Tropical Medicine, 3, 6, 2010. Crossref
-
Ali Shamsa, Fonseca Vivian, Overview of metformin: special focus on metformin extended release, Expert Opinion on Pharmacotherapy, 13, 12, 2012. Crossref
-
Argoff Charles E, Chen Cuiping, Cowles Verne E, Clinical development of a once-daily gastroretentive formulation of gabapentin for treatment of postherpetic neuralgia: an overview, Expert Opinion on Drug Delivery, 9, 9, 2012. Crossref
-
Cowles Verne E., Gordi Toufigh, Hou Sui Yuen Eddie, Steady-State Pharmacokinetics of Gabapentin after Administration of a Novel Gastroretentive Extended-Release Formulation in Postmenopausal Women with Vasomotor Symptoms, Clinical Drug Investigation, 32, 9, 2012. Crossref
-
Chen Cuiping, Cowles Verne E., Sweeney Michael, Stolyarov Igor D., Illarioshkin Sergey N., Pharmacokinetics and Pharmacodynamics of Gastroretentive Delivery of Levodopa/Carbidopa in Patients With Parkinson Disease, Clinical Neuropharmacology, 35, 2, 2012. Crossref
-
Chen Cuiping, Han Chien-Hsuan (Sara), Sweeney Michael, Cowles Verne E., Pharmacokinetics, Efficacy, and Tolerability of a Once-Daily Gastroretentive Dosage Form of Gabapentin for the Treatment of Postherpetic Neuralgia, Journal of Pharmaceutical Sciences, 102, 4, 2013. Crossref
-
Chen Cuiping, Cowles Verne E., Sweeney Mike, Stolyarov Igor D., Illarioshkin Sergey N., Pharmacokinetics of Levodopa/Carbidopa Delivered From Gastric-Retentive Extended-Release Formulations in Patients With Parkinson's Disease, The Journal of Clinical Pharmacology, 52, 7, 2012. Crossref
-
Chen Cuiping, Cowles Verne E., Hou Eddie, Pharmacokinetics of Gabapentin in a Novel Gastric-Retentive Extended-Release Formulation: Comparison With an Immediate-Release Formulation and Effect of Dose Escalation and Food, The Journal of Clinical Pharmacology, 51, 3, 2011. Crossref
-
Prajapati Vipul D., Jani Girish K., Khutliwala Tohra A., Zala Bhumi S., Raft forming system—An upcoming approach of gastroretentive drug delivery system, Journal of Controlled Release, 168, 2, 2013. Crossref
-
Sugihara Hikaru, Matsui Yuji, Takeuchi Hirofumi, Wilding Ian, Connor Alyson, Abe Kazuya, Nishiura Akio, Development of a gastric retentive system as a sustained-release formulation of pranlukast hydrate and its subsequent in vivo verification in human studies, European Journal of Pharmaceutical Sciences, 53, 2014. Crossref
-
Pinkerton JoAnn V., Kagan Risa, Portman David, Sathyanarayana Rekha, Sweeney Michael, Phase 3 randomized controlled study of gastroretentive gabapentin for the treatment of moderate-to-severe hot flashes in menopause, Menopause, 21, 6, 2014. Crossref
-
Awasthi Rajendra, Kulkarni Giriraj T., Decades of research in drug targeting to the upper gastrointestinal tract using gastroretention technologies: where do we stand?, Drug Delivery, 23, 2, 2016. Crossref
-
Bardonnet P.L., Faivre V., Pugh W.J., Piffaretti J.C., Falson F., Gastroretentive dosage forms: Overview and special case of Helicobacter pylori, Journal of Controlled Release, 111, 1-2, 2006. Crossref
-
Kagan Leonid, Lapidot Noa, Afargan Michel, Kirmayer David, Moor Eytan, Mardor Yael, Friedman Michael, Hoffman Amnon, Gastroretentive Accordion Pill: Enhancement of riboflavin bioavailability in humans, Journal of Controlled Release, 113, 3, 2006. Crossref
-
Kagan L., Hoffman A., Biopharmaceutical aspects of gastro-retentive dosage forms: the gabapentin paradigm, Journal of Drug Delivery Science and Technology, 19, 4, 2009. Crossref
-
Kyada C., Ranch K., Shah D., Optimization of Mucoadhesive Microspheres of Acyclovir by Applying 32 Full Factorial Design, Journal of Drug Delivery Science and Technology, 24, 1, 2014. Crossref
-
Verhagen Metman Leo, Stover Natividad, Chen Cuiping, Cowles Verne E., Sweeney Michael, Gastroretentive carbidopa/levodopa, DM-1992, for the treatment of advanced Parkinson's disease, Movement Disorders, 30, 9, 2015. Crossref
-
Irving Gordon, Once-daily gastroretentive gabapentin for the management of postherpetic neuralgia: an update for clinicians, Therapeutic Advances in Chronic Disease, 3, 5, 2012. Crossref
-
Singh Bhupinder, Chakkal Sukhwinder Kaur, Ahuja Naveen, Formulation and optimization of controlled release mucoadhesive tablets of atenolol using response surface methodology, AAPS PharmSciTech, 7, 1, 2006. Crossref
-
Mahalingam Ravichandran, Jasti Bhaskara, Birudaraj Raj, Stefanidis Dimitrios, Killion Robert, Alfredson Tom, Anne Pratap, Li Xiaoling, Evaluation of Polyethylene Oxide Compacts as Gastroretentive Delivery Systems, AAPS PharmSciTech, 10, 1, 2009. Crossref
-
Scholes Peter, Zann Vanessa, Lin Wu, Roe Chris, Berner Bret, Oral Site-Directed Drug Delivery and Influence on PK, in Drug Delivery Approaches, 2021. Crossref
-
Irving Gordon, Once-daily gastroretentive gabapentin for treatment of postherpetic neuralgia, Pain Management, 2, 3, 2012. Crossref
-
Zhao Cheng, Cai Lijun, Chen Hanxu, Tan Hui, Yan Dewen, Oral biomaterials for intestinal regulation, Engineered Regeneration, 2, 2021. Crossref
-
Yin Lifang, Qin Chao, Chen Kaisheng, Zhu Chunli, Cao Hui, Zhou Jianping, He Wei, Zhang Qiang, Gastro-floating tablets of cephalexin: Preparation and in vitro/in vivo evaluation, International Journal of Pharmaceutics, 452, 1-2, 2013. Crossref
-
Schwartz Sherwyn, Fonseca Vivian, Berner Bret, Cramer Marilou, Chiang Yu-Kun, Lewin Andrew, Efficacy, Tolerability, and Safety of a Novel Once-Daily Extended-Release Metformin in Patients With Type 2 Diabetes, Diabetes Care, 29, 4, 2006. Crossref